Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $395.81 million as of June 16, 2026. Its market cap has decreased by -31.39% in one year.

Market Cap

395.81M

Enterprise Value

380.77M

Revenue

140.12M

Ranking

n/a

PE Ratio

10.32

Stock Price

$0.37

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 395.81M, an increase of 4,033.70%. That is a compound annual growth rate of 14.26%.

Market Cap History

Date	Market Cap	% Change
Jun 15, 2026	395.81M	-24.86%
Dec 31, 2025	526.74M	-8.88%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Glass House Brands	1.13B
Nika Pharmaceuticals	212.44M
Jushi Holdings	95.12M
Sofgen Pharma	58.35M
Earth Science Tech	52.25M
Growth Stalk Holdings	46.05M
Healthy Extracts	45.61M
Radnostix	37.04M

Market Cap Rankings